Making Nissui Pharmaceutical as a Wholly-Owned SubsidiaryExpanding the Clinical Testing Business Based on Synergies between Analytical and Measuring Instruments and Culture Media/Reagents November 18, 2022November 18, 2022 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: Making Nissui Pharmaceutical as a Wholly-Owned…Growth Strategy for Analytical & Measuring…Highly Flame Resistant Cellulose Fiber Composite…Cytiva acquires Intermountain Life Sciences; will…Avantor® to Collaborate with GeminiBio to Bring…Shimadzu Releases Amyloid MS CL System for Measuring…Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)
